RNA interference
| 8 min read
Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.
Available on Demand
Optimizing the chemical architecture of siRNA improves its therapeutic potential for neurodegenerative disorders.
Available on Demand
Noncoding RNA molecules are involved in key cellular processes affecting neurodevelopment and immunity.
Page 1 of 1 - 3 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
Preparing data for AI/ML predictive modeling
Mastering data preparation is key to harnessing the full potential of advanced computational tools.
A Technology Guide for CRISPR Screening
Emerging CRISPR screening methods are shaping what’s possible in drug development and precision medicine.
